This study examined whether the work of the Centers for Education and Research on Therapeutics, the Coordinating Center and its grantees, influenced achievement of the Pharmaceutical Outcomes Portfolio goals and contributed to the sponsoring agency´s mission. These goals and mission included enhancing patient, provider, and policy maker understanding of the safety of drugs, biologic products, and medical devices. The study included social network analysis, site visits and telephone discussions with stakeholders and grantees, document review, case studies, and appreciative inquiry.
The study confirmed that the Pharmaceutical Outcomes Portfolio goals provided a good fit with the mission of the Agency for Healthcare Research and Quality to improve the quality, safety, efficiency, and effectiveness of healthcare for all Americans. The Portfolio contributed to progress toward those goals. The program contributed to patients´, providers´, and policy makers understanding of the safety of drugs, biological products, and medical devices. These contributions were achieved through research and education programs that focused on understanding and communicating objective information about the risks and benefits of therapeutic agents used in treatment.
Report Title: Evaluation of AHRQ's Pharmaceutical Outcomes Portfolio. Report may be obtained from Federal Contact
Agency Sponsor: AHRQ, Agency for Healthcare Research and Quality
Federal Contact: Scott Smith, 301-427-1511
Performer: Abt Associates Inc
PIC ID: 8594